AG
SYRS
Artal Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,505,013
| Closed | -$12.9M | – | 105 |
|
|
2024
Q2 | $12.9M | Hold |
2,505,013
| – | – | 0.33% | 34 |
|
|
2024
Q1 | $13.4M | Hold |
2,505,013
| – | – | 0.34% | 34 |
|
|
2023
Q4 | $19.5M | Buy |
2,505,013
+1,029,269
| +70% | +$8.02M | 0.65% | 21 |
|
|
2023
Q3 | $5.83M | Hold |
1,475,744
| – | – | 0.25% | 53 |
|
|
2023
Q2 | $4.65M | Hold |
1,475,744
| – | – | 0.14% | 65 |
|
|
2023
Q1 | $3.94M | Buy |
1,475,744
+11,915
| +0.8% | +$31.8K | 0.23% | 66 |
|
|
2022
Q4 | $5.26M | Hold |
1,463,829
| – | – | 0.29% | 57 |
|
|
2022
Q3 | $9.43M | Sell |
1,463,829
-2,536,171
| -63% | -$16.3M | 0.4% | 42 |
|
|
2022
Q2 | $3.85M | Buy |
4,000,000
+500,000
| +14% | +$481K | 0.21% | 65 |
|
|
2022
Q1 | $4.17M | Buy |
3,500,000
+500,000
| +17% | +$595K | 0.17% | 86 |
|
|
2021
Q4 | $9.78M | Buy |
3,000,000
+1,000,000
| +50% | +$3.26M | 0.27% | 64 |
|
|
2021
Q3 | $8.94M | Buy |
2,000,000
+300,000
| +18% | +$1.34M | 0.2% | 79 |
|
|
2021
Q2 | $9.27M | Buy |
1,700,000
+675,000
| +66% | +$3.68M | 0.19% | 85 |
|
|
2021
Q1 | $7.67M | Buy |
1,025,000
+275,000
| +37% | +$2.06M | 0.14% | 98 |
|
|
2020
Q4 | $8.14M | Buy |
750,000
+284,500
| +61% | +$3.09M | 0.17% | 87 |
|
|
2020
Q3 | $4.12M | Sell |
465,500
-24,500
| -5% | -$217K | 0.1% | 89 |
|
|
2020
Q2 | $5.22M | Sell |
490,000
-16,138
| -3% | -$172K | 0.15% | 88 |
|
|
2020
Q1 | $3M | Buy |
+506,138
| New | +$3M | 0.13% | 81 |
|